Navigation Links
Celsion Reports Third Quarter 2010 Financial Results and Provides Business Update
Date:11/15/2010

COLUMBIA, Md., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, today announced financial results for the third quarter and nine months ended September 30, 2010 and addressed the progress of its clinical trials of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.  ThermoDox® is currently being evaluated under a Special Protocol Assessment with the FDA in a 600 patient pivotal Phase III trial (the HEAT study) in patients with non-resectable primary liver cancer and in a Phase I/II trial for patients with recurrent chest wall breast cancer.   The HEAT study has been designated as a Priority Trial for liver cancer by the National Institutes of Health.

"We are approaching 80% completion of patient enrollment into our Phase III primary liver cancer HEAT study of ThermoDox®.  Together with our Special Protocol Assessment for the HEAT study, Celsion received Fast Track Designation from the FDA providing us with the opportunity to file our New Drug Application on a rolling basis.  We now have an efficient clinical and regulatory pathway for commercialization of ThermoDox®," said Michael Tardugno, Celsion's President and Chief Executive Officer.Financial Results For the third quarter ended September 30, 2010, Celsion reported a net loss from operations of $5.2 million compared to a net loss from operations of $4.7 million for the same period of 2009.  For the first nine months of 2010, net cash used in operations was $10.6 million.  Celsion reported a net loss from operations of $14.2 million for the first nine months of 2010 compared to a net loss from operations of $13.2 million for the same period of 2009.  In the third quart
'/>"/>

SOURCE Celsion Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Celsion Announces Date and Time Change for Third Quarter 2010 Financial Results Conference Call to Monday, November 15, 2010
2. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
3. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
4. Par Pharmaceutical Reports Second Quarter 2008 Results
5. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
6. Pharmos Corporation Reports 2008 Second Quarter Results
7. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
8. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
9. BMP Sunstone Reports Second Quarter 2008 Financial Results
10. ULURU Inc. Reports Second Quarter 2008 Financial Results
11. Immtech Reports Fiscal First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... On April 19th the Center for ... for the growing antibiotic resistant bacteria that may be ... long study were released late last month showing higher ... previous years. For those suffering from bacteria driven acne, ... bacteria in food, may eventually help breed acne causing ...
(Date:5/23/2013)... DC (PRWEB) May 23, 2013 The ... in STEM industries, Black Data Processing Associates (BDPA), is ... on June 8, 2013. This all-day event will encourage ... and learn the ins and outs from many of ... 3 p.m. at the New Jersey Institute of Technology, ...
(Date:5/23/2013)... During the conduct of research involving ... principles of good clinical practice (GCP) and human ... Lim, Fellow, Clinical Development at Novartis Pharmaceuticals, will ... the International Conference on Harmonization (ICH) Guideline for ... the conduction of clinical trials ,     Apply ...
(Date:5/23/2013)... African Ancestry , Inc., the ... African descent, today announced new product enhancements to ... all races, myDNAmix determines various ancestries included in ... Americas (Native American), East Asia, West Sub-Saharan Africa, ... Originally launched in late 2011, the enhanced product ...
Breaking Biology Technology:Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3
... , , , ... , , , , ... cell proliferation plays an,essential role in the homeostasis of cell numbers ... and,other influences [1-3]. There are two distinct ways of,eukaryotic cell death: ...
... , ... , , , , ... is now a routine procedure in many laboratories.,Protocols are available ... growth,factors, inhibition of cell division by exogenous factors,stimulation/inhibition by cytokines, ...
... , , ... , , , ... (DPD), and thymidylate,synthase (TS) play a pivotal role in the ... (5-FU) is the standard,chemotherapy treatment for a wide range of ...
Cached Biology Technology:Quantification of Nucleosomes in Serum,by the Cell Death Detection ELISAplus 2Quantification of Nucleosomes in Serum,by the Cell Death Detection ELISAplus 3Quantification of Nucleosomes in Serum,by the Cell Death Detection ELISAplus 4Quantification of Nucleosomes in Serum,by the Cell Death Detection ELISAplus 5Quantification of Nucleosomes in Serum,by the Cell Death Detection ELISAplus 6Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 2Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 3Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 4Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 5Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 6Gene-Expression Analysis of TP, DPD, and TS Using,the LightCycler mRNA Quantification KitsPLUS 2Gene-Expression Analysis of TP, DPD, and TS Using,the LightCycler mRNA Quantification KitsPLUS 3Gene-Expression Analysis of TP, DPD, and TS Using,the LightCycler mRNA Quantification KitsPLUS 4
(Date:5/23/2013)... succeeded in treating cerebral palsy with autologous cord blood. ... 2.5 year old boy had been in a persistent ... two months after treatment with the cord blood containing ... months, the child learned to speak simple sentences and ... Korean study, dispel the long-held doubts about the effectiveness ...
(Date:5/23/2013)... MADISON, Wis. In an age when microbial pathogens ... to tamp down infection, a team of Wisconsin scientists ... of curbing the bacteria that cause staph infections. , ... Chemical Society , a group led by University of ... interfere with the "quorum sensing" behavior of Staphylococcus ...
(Date:5/22/2013)... developed a novel technique that can detect molecular variants ... is one of the most important, though time-consuming, processes ... paper in Nature , post-doctoral researcher David Patterson, ... of the Center for Free-Electron Laser Science (CFEL) in ... microwave fields to identify molecular variants apart, and to ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2University of Wisconsin chemists find new compounds to curb staph infection 2Detecting mirror molecules 2Detecting mirror molecules 3
... 8, 2009) Van Andel Research Institute ... an important therapeutic target in the treatment of the ... these cancers have few treatment options. "Breast cancer ... don,t respond to traditional treatments tend to be more ...
... self-organizing systems are the Holy Grails of nanotechnology, but ... years. A team of scientists has taken a unique ... able to assemble into clusters that direct cell movement ... valuable insight into how complex periodic patterns in biological ...
... 2009 Alexopoulos Prize will be given to Dr. Brian Shaw, ... July 29 in Snowbird, Utah. The honor based ... also known as the Outstanding Early-Career Mycologist Award of the ... papers and four review papers in 12 years. Both the ...
Cached Biology News:Possible drug target found for one of the most aggressive breast cancers 2Spontaneous assembly 2Spontaneous assembly 3Spontaneous assembly 4
Mouse monoclonal [CIa] to Ia Antigen (Biotin) ( Abpromise for all tested applications)....
RNA polymerase sigma 70 Immunogen: Recombinant, full length protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
... polyclonal to MSY2/YBOX2 ( Abpromise ... Antigen: Synthetic peptide derived ... C-terminus of Human MSY2/YBOX2. (Note: ... (Peptide available as ...
Biology Products: